How many institutions held APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value in Q2 2024?

18 institutional investors reported APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value for Q2 2024. Use the holders table for investor-level position and value details.

Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO)

Q: What does CUSIP 03835L306 represent in this 13F holders report?

CUSIP 03835L306 is the security identifier for APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 03835L306

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 2,864,322
Total 13F shares: 1,963,743
Share change: +1,961,100
Total reported value: $599,087
Price per share: $0.31
Number of holders: 18
Value change: +$598,269
Number of buys: 11
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 03835L306?
CUSIP 03835L306 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 03835L306:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Tower Research Capital LLC (TRC)	13F	Company	0.05%	1,324	$6,209	—	31 Mar 2024	13F
BlackRock Finance, Inc.	13F	Company	0.03%	890	$4,174	—	31 Mar 2024	13F
MORGAN STANLEY	13F	Company	0.01%	194	$910	—	31 Mar 2024	13F
Qube Research & Technologies Ltd	13F	Company	0%	100	$469	—	31 Mar 2024	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	45	$211	—	31 Mar 2024	13F
JPMORGAN CHASE & CO	13F	Company	0%	43	$202	—	31 Mar 2024	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	36	$169	—	31 Mar 2024	13F
FIFTH THIRD BANCORP	13F	Company	0%	6	$28	—	31 Mar 2024	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0%	3	$14	—	31 Mar 2024	13F
Truvestments Capital LLC	13F	Company	0%	2	$9	—	31 Mar 2024	13F
Fuad El-Hibri	3/4/5	Director	— class O/S missing	87,697	—	—	03 Dec 2021	3/4/5

Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) as of Q2 2024

As of 30 Jun 2024, Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,963,743 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Hudson Bay Capital Management LP, UBS Group AG, HRT FINANCIAL LP, Baader Bank Aktiengesellschaft, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, Tower Research Capital LLC (TRC), and BlackRock Inc.. This page lists 18 institutional shareholders reporting positions in this security for the Q2 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 Value $	Q2 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.